| Anterior Pharynx Defective 1 (APH-1) | |
|---|---|
| Gene | APH1A, APH1B |
| UniProt | Q9WVM4 (APH-1A), Q8WW43 (APH-1B) |
| PDB | 5A63, 6IDF |
| Mol. Weight | ~35 kDa (APH-1A: 346 aa, APH-1B: 350 aa) |
| Localization | Endoplasmic reticulum, Golgi apparatus, plasma membrane |
| Family | APH-1 family (γ-secretase complex) |
| Diseases | Alzheimer's Disease, Frontotemporal Dementia |
Anterior Pharynx Defective 1 (Aph 1) Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Anterior Pharynx Defective 1 (APH-1) is a conserved multipass transmembrane protein that serves as an essential stoichiometric component of the γ-secretase complex[1]. The complex, which also includes presenilin (PSEN), nicastrin (NCT), and PEN-2, is responsible for the intramembranous proteolysis of amyloid precursor protein (APP) and over 100 other type I transmembrane substrates. APH-1 exists in two paralogs in humans - APH-1A and APH-1B - which have distinct tissue expression patterns and functional properties[2].
APH-1 was originally identified in C. elegans as a component of the Notch signaling pathway, where mutations caused developmental defects in pharynx formation. In mammals, APH-1 plays crucial roles in γ-secretase assembly, substrate specificity, and the pathogenesis of Alzheimer's disease[3].
APH-1 is a 7-transmembrane domain protein with both N- and C-termini located in the luminal/extracellular space.
APH-1 plays critical roles in γ-secretase complex biogenesis:
The γ-secretase complex processes numerous substrates:
APH-1 influences γ-secretase activity and Aβ production:
Understanding APH-1's role has led to therapeutic strategies:
Dysregulated γ-secretase activity affects:
The study of Anterior Pharynx Defective 1 (Aph 1) Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Goutte C, Tsunozaki M, Hale VA, et al. APH-1 is a key component of the γ-secretase complex required for Notch signal transduction. Curr Biol. 2002;12(1):101-105. DOI:10.1016/S0960-9822(01)00638-1 ↩︎
LaVoie MJ, Fraering PC, Ostaszewski BL, et al. Assembly of the γ-secretase complex involves early formation of an intermediate subcomplex of Aph-1 and Nicastrin. J Biol Chem. 2003;278(38):37213-37222. DOI:10.1074/jbc.M303267200 ↩︎
He G, Luo W, Li P, et al. Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease. Nature. 2010;467(7311):95-98. DOI:10.1038/nature09325 ↩︎